BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170909
DTEND;VALUE=DATE:20171010
DTSTAMP:20260729T094042
CREATED:20170909T095108Z
LAST-MODIFIED:20170909T095331Z
UID:19047-1504915200-1507593599@ces.b2sg.org
SUMMARY:Postdoctoral Opportunities
DESCRIPTION:Laboratory postdoctoral openings: \n• Studies on isoform-specific signaling by PI 3-kinase in tumor metastasis.\nJonathan M. Backer\, MD – Departments of Molecular Pharmacology and Biochemistry \n• Host-Microbe interactions\, microbial genetics\, metagenomics/metabolomics\, inflammation and cancer.\nSridhar Mani\, MD – Departments of Genetics and Medicine \n• Studies on the pro-metastatic protein S100A4 in host-tumor cell interactions during metastasis.\nAnne R. Bresnick\, PhD – Department of Biochemistry \n• Role of DNA modifying enzymes in epigenetic regulation of normal and malignant hematopoiesis\nMeelad Dawlaty\, PhD – Department of Genetics \n• The role of stem cell programs in breast cancer.\nWenjun Guo\, PhD – Department of Cell Biology \n• Development of a procedure to cure sickle cell disease by gene modification in LT-HSCs.\n• Hematopoietic stem cell aging and expression variability. \nEric Bouhassira\, PhD – Departments of Cell Biology and Medicine (Hematology) \n• Cell signaling in normal biology and cancer.\nMarina Holz\, PhD – Department of Molecular Pharmacology \n• Regulation and physiological role of Endosomal Microautophagy (eMI) selective for soluble\, KFERQ-motif containing substrates\, for which we recently have developed a genetic system \nAndreas Jenny\, PhD – Departments of Developmental & Molecular Biology and Genetics \n• Anti-cancer mechanism of methylthioadenosine phosphate inhibitors.\nVern Schramm\, PhD – Department of Biochemistry \n• New immune checkpoints and cancer immunotherapies.\nXingxing Zang\, PhD – Departments of Microbiology/Immunology\, Medicine (Oncology) and\nUrology \n• Molecular and therapeutic Immunomodulation of the immune system to cure HIV infection and prevent neuroAIDS.\nHarris Goldstein\, MD – Departments of Pediatrics and Microbiology/Immunology \n• Development of small molecule drugs to protect the heart during cancer treatments \nRichard Kitsis\, MD – Departments of Medicine and Cell Biology; Evripidis Gavathiotis\, PhD Departments of Biochemistry and Medicine \n• Potential differences in gene regulation in lungs and lung tumors among individuals\, using genetic and epigenetic techniques.\nSimon Spivack\, MD\, MPH – Departments of Medicine (Pulmonary medicine)\, Epidemiology & Prevention Health and Genetics \n• Molecular analysis of DNA replication and repair at cancer-associated sites in the human genome – Carl Schildkraut\, PhD – Professor\, Department of Cell Biology \nLearn more about the Albert Einstein Cancer Center and the Postdoctoral training opportunities\, research programs and faculty mentors at:\nwww.einstein.yu.edu/cancer \nFor a more detailed description of postdoctoral research projects go to:\nhttp://www.einstein.yu.edu/centers/cancer/resources/postdocs.aspx
URL:https://ces.b2sg.org/event/postdocs-einstein-sept17/
LOCATION:Albert Einstein College of Medicine\, 1300 Morris Park Ave\, Bronx\, NY\, 10461\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/07/logo-albert-einstein-college-of-medicine-e1504950783797.jpg
END:VEVENT
END:VCALENDAR